Across TCGA pan-cancer cohorts, NPM1P6 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated NPM1P6 data layer.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher NPM1P6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NPM1P6 expression acts as an unfavorable survival marker, although some lineages such as KIRC and MESO show a favorable association.
LIHC, KICH, and KIRP are the cancer types where NPM1P6 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.